159 related articles for article (PubMed ID: 23292002)
1. Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth.
Lin WR; Lai MW; Yeh CT
Oncol Rep; 2013 Mar; 29(3):903-10. PubMed ID: 23292002
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cyclin-dependent kinase-associated protein phosphatase enhances cell proliferation in renal cancer cells.
Lai MW; Chen TC; Pang ST; Yeh CT
Urol Oncol; 2012; 30(6):871-8. PubMed ID: 21396835
[TBL] [Abstract][Full Text] [Related]
3. KAP regulates ROCK2 and Cdk2 in an RNA-activated glioblastoma invasion pathway.
Li H; Jiang X; Yu Y; Huang W; Xing H; Agar NY; Yang HW; Yang B; Carroll RS; Johnson MD
Oncogene; 2015 Mar; 34(11):1432-41. PubMed ID: 24704824
[TBL] [Abstract][Full Text] [Related]
4. Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma.
Yeh CT; Lu SC; Chen TC; Peng CY; Liaw YF
Cancer Res; 2000 Sep; 60(17):4697-700. PubMed ID: 10987270
[TBL] [Abstract][Full Text] [Related]
5. Abolishment of the interaction between cyclin-dependent kinase 2 and Cdk-associated protein phosphatase by a truncated KAP mutant.
Yeh CT; Lu SC; Chao CH; Chao ML
Biochem Biophys Res Commun; 2003 May; 305(2):311-4. PubMed ID: 12745075
[TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation.
Xing C; Xie H; Zhou L; Zhou W; Zhang W; Ding S; Wei B; Yu X; Su R; Zheng S
Biochem Biophys Res Commun; 2012 Mar; 420(1):29-35. PubMed ID: 22390936
[TBL] [Abstract][Full Text] [Related]
7. CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.
Dai W; Miao H; Fang S; Fang T; Chen N; Li M
Mol Med Rep; 2016 Aug; 14(2):1509-14. PubMed ID: 27314282
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-Dependent Kinase Inhibitor 3 Promotes Cancer Cell Proliferation and Tumorigenesis in Nasopharyngeal Carcinoma by Targeting p27.
Wang H; Chen H; Zhou H; Yu W; Lu Z
Oncol Res; 2017 Nov; 25(9):1431-1440. PubMed ID: 28109073
[TBL] [Abstract][Full Text] [Related]
9. P21-activated kinase 5 plays essential roles in the proliferation and tumorigenicity of human hepatocellular carcinoma.
Fang ZP; Jiang BG; Gu XF; Zhao B; Ge RL; Zhang FB
Acta Pharmacol Sin; 2014 Jan; 35(1):82-8. PubMed ID: 23685956
[TBL] [Abstract][Full Text] [Related]
10. A critical role of CDKN3 in Bcr-Abl-mediated tumorigenesis.
Chen Q; Chen K; Guo G; Li F; Chen C; Wang S; Nalepa G; Huang S; Chen JL
PLoS One; 2014; 9(10):e111611. PubMed ID: 25360622
[TBL] [Abstract][Full Text] [Related]
11. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
12. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.
Iwagami Y; Huang CK; Olsen MJ; Thomas JM; Jang G; Kim M; Lin Q; Carlson RI; Wagner CE; Dong X; Wands JR
Hepatology; 2016 Apr; 63(4):1213-26. PubMed ID: 26683595
[TBL] [Abstract][Full Text] [Related]
13. DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2.
Sun J; Wang X; Shen Q; Wang M; Chen S; Zhang X; Huang Y; Zhang Z; Li W; Yuan Y; Huang Z
Cell Oncol (Dordr); 2022 Dec; 45(6):1187-1202. PubMed ID: 36327092
[TBL] [Abstract][Full Text] [Related]
14. Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E.
Yue X; Zhang Z; Liang X; Gao L; Zhang X; Zhao D; Liu X; Ma H; Guo M; Spear BT; Gong Y; Ma C
Gastroenterology; 2012 Jun; 142(7):1559-70.e2. PubMed ID: 22406477
[TBL] [Abstract][Full Text] [Related]
15. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
17. Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma.
Mok WC; Wasser S; Tan T; Lim SG
World J Gastroenterol; 2012 Jul; 18(27):3527-36. PubMed ID: 22826617
[TBL] [Abstract][Full Text] [Related]
18. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
19. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression.
Lee SW; Reimer CL; Fang L; Iruela-Arispe ML; Aaronson SA
Mol Cell Biol; 2000 Mar; 20(5):1723-32. PubMed ID: 10669749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
